Log In
Print
BCIQ
Print
Print this Print this
 

Stivarga, regorafenib (fluoro-sorafenib) (BAY 73-4506)

Also known as: DAST Inhibitor

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionDual acting signal transduction (DAST) inhibitor of multiple kinases
Molecular Target Vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) (VEGFR-2) ; Tyrosine kinase receptor 2 (Tie2)
Mechanism of ActionVascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) kinase inhibitor; Tyrosine kinase receptor 2 (Tie2) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today